Concepedia

Kenisha Arthur

KA

Statistics

Publications

5

Citations

194

H-Index

5

Active since

2020

Affiliations

The University of Texas MD Anderson Cancer Center(Current)

Beth Israel Deaconess Medical Center

The University of Texas Health Science Center at Houston

Harvard University

BioVentures (United States)

Kenisha Arthur is an author at The University of Texas MD Anderson Cancer Center specializing in cancer therapeutics, cancer research, and medicine.

Top concepts

Publications per year

2020–2022

5

Publications

5

An enolase inhibitor for the targeted treatment of ENO1-deleted cancers

Yu-Hsi Lin, Nikunj Satani, Naima Hammoudi et al. · Nature Metabolism · 2020 · 95 citations · Full text

, , +5

Homozygous MTAP deletion in primary human glioblastoma is not associated with elevation of methylthioadenosine

Yasaman Barekatain, Jeffrey J. Ackroyd, Victoria C. Yan et al. · Nature Communications · 2021 · 49 citations · Full text

Impaired anaplerosis is a major contributor to glycolysis inhibitor toxicity in glioma

Sunada Khadka, Kenisha Arthur, Yasaman Barekatain et al. · Cancer & Metabolism · 2021 · 22 citations · Full text

Pharmacokinetics of Orally Administered GS-441524 in Dogs

Victoria C. Yan, Cong-Dat Pham, Matthew J. Yan et al. · 2021 · 18 citations · Full text

Prodrugs of a 1-Hydroxy-2-oxopiperidin-3-yl Phosphonate Enolase Inhibitor for the Treatment of <i>ENO1</i>-Deleted Cancers

Victoria C. Yan, Cong-Dat Pham, Elliot Ballato et al. · Journal of Medicinal Chemistry · 2022 · 10 citations · Full text

1–5 of 5